190906-92-4

Usage

Uses

Used in Pharmaceutical Industry:
1-BOC-2-METHYL-PIPERIDIN-4-ONE is used as a precursor in the synthesis of drugs for its ability to facilitate chemical reactions, contributing to the development of new pharmaceutical compounds.
Used in Agrochemical Industry:
1-BOC-2-METHYL-PIPERIDIN-4-ONE is used as a precursor in the production of pesticides, enabling the creation of effective agrochemicals to protect crops and enhance agricultural productivity.
Used in Production of Pharmaceutical Intermediates:
1-BOC-2-METHYL-PIPERIDIN-4-ONE is utilized as a key intermediate in the synthesis of various pharmaceuticals, playing a significant role in the development of medicinal compounds.
It is important to handle and store 1-BOC-2-METHYL-PIPERIDIN-4-ONE with care due to its potential health and environmental hazards, ensuring safety in its applications across different industries.

InChI:InChI=1/C11H19NO3/c1-8-7-9(13)5-6-12(8)10(14)15-11(2,3)4/h8H,5-7H2,1-4H3

Upstream product

• 346424-89-3 C₁₄H₂₅NO₆ 
• 13729-77-6 2-methyl-piperidin-4-one hydrochloride 
• 24424-99-5 di-tert-butyl dicarbonate 
• 71322-99-1 2-methyl-4-oxopiperidine 
• 126503-08-0 N-Boc-7-methyl-1,4-dioxa-8-azaspiro<4.5>decane 
• 1382774-58-4 2-methyl-4-piperidinone acetate 
• 849928-34-3 benzyl 2-methyl-4-oxopiperidine-1-carboxylate 
• 620-08-6 4-methoxypyridine 
• 865-47-4 potassium tert-butylate 
• 676-58-4 methylmagnesium chloride 

Downstream Products

• 346592-35-6 4-(5-fluoro-benzo[b]thiophen-2-yl)-4-hydroxy-2-methyl-piperidine-1-carboxylic acid tert-butyl ester 
• 676490-95-2 C₁₉H₂₄N₂O₂ 
• 152491-46-8 (rac)-tert-butyl (cis)-4-hydroxy-2-methylpiperidine-1-carboxylate 
• 152491-46-8 (rac)-tert-butyl (trans)-4-hydroxy-2-methylpiperidine-1-carboxylate 
• 790667-44-6 tert-butyl (2R,4R)-4-hydroxy-2-methylpiperidine-1-carboxylate 
• 790668-06-3 (2R,4S)-tert-butyl 4-hydroxy-2-methylpiperidine-1-carboxylate 
• 790667-91-3 (2S,4R)-tert-butyl 4-hydroxy-2-methylpiperidine-1-carboxylate 
• 790667-99-1 tert-butyl (2S,4S)-4-hydroxy-2-methyl-piperidine-1-carboxylate 
• 1274805-20-7 2-methyl-4-{3-[4-((R)-3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-3-trifluoromethanesulfonyl-benzenesulfonylamino]-5,6-dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl}piperidine-1-carboxylic acid tert-butyl ester 
• 1383776-71-3 tert-butyl2-((3-chlorophenyl)amino)-7-methyl-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate 
• 1383776-73-5 N-(3-chlorophenyl)-7-methyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine 
• 251107-38-7 tert-butyl 4-benzyl-2-methylpiperidine-1-carboxylate 

Relevant academic research and scientific papers

A 1 - tert-butoxy carbonyl -2 - methyl -4 - piperidone method for the synthesis of

The invention discloses a synthesis method of 1-tertbutyloxycarbonyl-2-methyl-4-piperidone. The synthesis method comprises the following steps: step one, synthesis of 1-Cbz-2-methyl-3,4-dihydro-4-piperidone; step two, synthesis of 1-Cbz-2-methyl-4-piperid

TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS

The present invention relates to inhibitors of bromo and extra terminal (BET) bromodomains that are useful for the treatment of cancer, inflammatory diseases, diabetes, and obesity, having Formula (I): wherein W, X, Y, Z, R1, R2, R5, and R8 are as described herein.

MACROCYCLIC SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The present invention is directed to compounds of formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

FUSED TRICYCLIC DERIVATIVES FOR THE TREATMENT OF PSYCHOTIC DISORDERS

Compounds of formula (I) wherein R1, R2, X, A, Y, B, Z1, Q, p, r and s are defined in the specification for treating inter alia psychotic disorders, depressive disorders, anxiety disorders and sexual dysfunctions.

Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha

The present application describes novel β-amino acid derivatives of formula I: or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, X, Z, Ua, Xa, Ya, Za, R1, R2, R3

Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with new piperidine 4-alkenyl derivatives that possess unique antiviral activity. More particularly, the present invention relates to compounds useful for the treatment of HIV and AIDS. The compounds of the invention for the general Formula I: wherein: Z is Q is selected from the group consisting of: —W— is

Indole derivatives for the treatment of depression and anxiety

The present invention provides compounds of formula (I): which are useful for treating depression, anxiety, and alleviating the symptoms caused by withdrawal or partial withdrawal from the use of tobacco or of nicotine.

Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with new piperidine 4-alkenyl derivatives that possess unique antiviral activity. More particularly, the present invention relates to compounds useful for the treatment of HIV and AIDS. The compounds of the invention for the general Formula I: wherein: Z is Q is selected from the group consisting of: —W— is

SEROTONERGIC BENZOTHIOPHENES

The present invention provides serotonergic benzothiophenes of Formula (I), where A, R, R, R, R, and R are as described in the specification.